Skip to main content
. 2018 Feb 13;7(5):e1426516. doi: 10.1080/2162402X.2018.1426516

Figure 7.

Figure 7.

IGFBP2 is a prognostic predictor in GBM patients. (A-D) Kaplan-Meier survival analysis revealed that a high level of IGFBP2 indicated an unfavorable outcome in GBM patients of the CGGA and TCGA datasets. (E-H) Cox regression analysis was used to assess the prognostic value of IGFBP2 expression among other factors in the CGGA and TCGA datasets.